Why is this medication prescribed?

Fulphila is prescribed primarily to reduce the risk of infection in patients undergoing chemotherapy. Chemotherapy often suppresses the bone marrow’s ability to produce white blood cells, which are essential for fighting off infections. Fulphila belongs to a class of medications known as granulocyte colony-stimulating factors (G-CSFs), which work by stimulating the production of white blood cells in the bone marrow.

By boosting the production of white blood cells, Fulphila helps reduce the risk of infections in patients undergoing chemotherapy. Infections can be a significant concern for individuals undergoing chemotherapy because their weakened immune systems make them more susceptible to bacterial and fungal infections. By maintaining an adequate level of white blood cells, Fulphila can help prevent potentially serious infections and allow patients to continue their cancer treatment without interruption.

How should this medicine be used?

Fulphila is typically administered as a subcutaneous injection, which means it is injected under the skin. Here are general guidelines for how Fulphila should be used:

• Administration: Fulphila injections are usually given by a healthcare professional, such as a nurse or doctor. However, in some cases, patients may be taught how to self-administer the injections at home. Always follow the specific instructions provided by your healthcare provider.
• Injection site: The injection is typically given into the fatty tissue just under the skin, usually in the abdomen (belly) area or the front of the thighs. Your healthcare provider will advise you on the best injection site and technique.
• Dosage: The dosage of Fulphila and the frequency of injections will be determined by your healthcare provider based on factors such as your body weight, the type of cancer being treated, and other individual factors. Do not change the dosage or frequency of injections without consulting your healthcare provider.
• Timing: Fulphila is usually administered within 24 to 72 hours after completing a chemotherapy cycle. Your healthcare provider will give you specific instructions on the timing of injections based on your treatment schedule.
• Handling: Fulphila injections should be stored according to the manufacturer’s instructions, typically in the refrigerator. Do not freeze Fulphila, and protect it from light. Before administration, allow the medication to come to room temperature for about 30 minutes.
• Injection technique: Your healthcare provider will demonstrate the proper technique for administering Fulphila injections. This typically involves cleaning the injection site with an alcohol swab, pinching the skin to create a small fold, inserting the needle at a 45 to 90-degree angle, injecting the medication, and then removing the needle.
• Monitoring: Your healthcare provider may monitor your white blood cell counts regularly during chemotherapy treatment to determine if Fulphila is effectively boosting your immune system.

Always follow your healthcare provider’s instructions carefully when using Fulphila. If you have any questions or concerns about the administration of Fulphila or its side effects, be sure to discuss them with your healthcare provider.

Other uses for this medicine

Fulphila (pegfilgrastim) is primarily used to reduce the risk of infection in patients undergoing chemotherapy, particularly those with certain types of cancer. However, it may have other potential uses or off-label uses as determined by healthcare providers. Some healthcare providers might prescribe it for conditions or situations not listed in the official prescribing information.

What special precautions should I follow?

As for special precautions when using Fulphila, here are some important points to consider:

• Allergies: Inform your healthcare provider if you have any known allergies to pegfilgrastim or any other medications. Allergic reactions to Fulphila are rare but can occur.
• Bone pain: Bone pain is a common side effect of pegfilgrastim, including Fulphila. Inform your healthcare provider if you experience severe or persistent bone pain after receiving the injection.
• Splenomegaly (enlarged spleen): Fulphila can cause the spleen to become enlarged, which can be a serious complication. Inform your healthcare provider if you experience symptoms such as left-sided abdominal pain or fullness, feeling full after eating a small amount of food, or unusual tiredness.
• Blood disorders: Fulphila may increase the risk of developing certain blood disorders, such as sickle cell disease or thrombocytopenia (low platelet count). Inform your healthcare provider if you have a history of blood disorders.
• Use during pregnancy and breastfeeding: The safety of Fulphila during pregnancy and breastfeeding has not been established. Inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before using Fulphila.
• Interactions with other medications: Inform your healthcare provider about all the medications you are taking, including prescription drugs, over-the-counter medications, vitamins, and herbal supplements. Some medications may interact with Fulphila, affecting its effectiveness or increasing the risk of side effects.
• Monitoring: Your healthcare provider may monitor your white blood cell counts and other blood parameters regularly during treatment with Fulphila to assess its effectiveness and detect any potential complications.

Always follow your healthcare provider’s instructions and advice regarding the use of Fulphila, including any special precautions or monitoring requirements. If you have any questions or concerns about Fulphila or its potential uses, discuss them with your healthcare provider.

What special dietary instructions should I follow?

There are no specific dietary restrictions associated with Fulphila. However, maintaining a healthy and balanced diet is generally recommended during chemotherapy treatment to support overall health and well-being. Be sure to stay hydrated and consume a variety of nutrient-rich foods, including fruits, vegetables, lean proteins, and whole grains. If you have specific dietary concerns or restrictions, consult with a registered dietitian or nutritionist for personalized guidance.

What should I do if I forget a dose?

If you miss a dose of Fulphila, contact your healthcare provider or oncology team for guidance. Depending on your treatment plan and the timing of the missed dose, they may recommend rescheduling the injection or adjusting your treatment schedule accordingly. It’s essential not to double the dose to make up for a missed one unless specifically instructed by your healthcare provider.

What side effects can this medication cause?

Fulphila (pegfilgrastim) may cause various side effects, although not everyone experiences them. Common side effects of Fulphila include:

• Bone Pain: This is one of the most commonly reported side effects of Fulphila. It often manifests as pain in the long bones, such as the hips, legs, or arms. The pain is usually mild to moderate and may last for a few days following the injection.
• Muscle Pain: Some individuals may experience muscle pain or discomfort after receiving Fulphila injections.
• Headache: Headaches are another relatively common side effect associated with Fulphila use.
• Fatigue: Feeling tired or fatigued is a possible side effect of Fulphila.
• Nausea: Nausea or stomach discomfort may occur in some individuals after receiving Fulphila injections.
• Injection Site Reactions: Pain, redness, or swelling at the injection site are possible side effects of Fulphila.
• Fever: A low-grade fever is a potential side effect of Fulphila.
• Allergic Reactions: Although rare, allergic reactions to Fulphila may occur. Symptoms of an allergic reaction may include rash, itching, swelling, dizziness, or difficulty breathing. Seek medical attention immediately if you experience signs of an allergic reaction.
• Splenomegaly (Enlarged Spleen): Fulphila can cause enlargement of the spleen, which may lead to symptoms such as left-sided abdominal pain or fullness, feeling full after eating a small amount of food, or unusual tiredness.
• Serious Infections: While Fulphila is used to reduce the risk of infections, in rare cases, it may lead to serious infections. Contact your healthcare provider immediately if you develop signs of infection, such as fever, chills, cough, sore throat, or difficulty breathing.

It’s important to report any side effects or adverse reactions to your healthcare provider promptly. They can provide guidance on managing side effects and may adjust your treatment plan if necessary. If you experience severe or persistent side effects, seek medical attention right away.

What should I know about storage and disposal of this medication?

Storage and Disposal of Fulphila:

• Storage: Store Fulphila in the refrigerator between 36°F to 46°F (2°C to 8°C). Do not freeze. Keep the medication in its original packaging until ready to use to protect it from light. If necessary, Fulphila can be kept at room temperature (up to 77°F or 25°C) for a single period of up to 48 hours. Once taken out of the refrigerator, do not put it back. Keep it out of the reach of children and pets.
• Disposal: Dispose of used needles and syringes in a puncture-resistant container. Do not dispose of them in household trash. Follow local regulations for proper disposal of medical waste or ask your healthcare provider or pharmacist for guidance.

In case of emergency/overdose

In case of an emergency or suspected overdose of Fulphila, contact your healthcare provider, local poison control center, or go to the nearest emergency room immediately. Symptoms of overdose may include severe bone pain, difficulty breathing, dizziness, or fainting.

What other information should I know?

• Inform all healthcare providers involved in your care that you are using Fulphila.
• Attend all scheduled appointments for blood tests or other monitoring recommended by your healthcare provider.
• Follow your healthcare provider’s instructions carefully regarding the timing and dosage of Fulphila injections.
• Inform your healthcare provider of any new or worsening symptoms experienced during Fulphila treatment.
• Keep a record of the dates and times of Fulphila injections for reference.
• Do not share Fulphila with others, even if they have similar symptoms or conditions.
• Follow proper hand hygiene and infection control measures to reduce the risk of infections while undergoing chemotherapy treatment.
• If you have any questions or concerns about Fulphila or its use, don’t hesitate to discuss them with your healthcare provider or pharmacist.

Remember, the information provided here is not exhaustive. Always follow the specific instructions provided by your healthcare provider and refer to the medication guide or package insert for comprehensive details on storage, disposal, emergencies, and other important information related to Fulphila.